Inotek has sponsored Phase 1, Phase 2 and Phase 3 clinical trials for trabodenoson monotherapy which have concluded, as well as a Phase 2 clinical trial for trabodenoson + latanoprost in a fixed-dose combination. Click the links below to learn more about each trial through clinicaltrials.gov.

Identifier	Status	Therapy	Study Name
NCT02829996	Completed	Fixed-dose combination	Study of Fixed-Dose Combinations of Trabodenoson and Latanoprost in Adults With Ocular Hypertension or Primary Open-Angle Glaucoma
NCT02565173	Completed	Trabodenoson monotherapy	Study of Trabodenoson in Adults With Ocular Hypertension or Primary Open-angle Glaucoma
NCT01917383	Completed	Trabodenoson monotherapy	A Phase II Study to Evaluate the Additivity of Trabodenoson to Latanoprost in Adults With Ocular Hypertension or Primary Open-Angle Glaucoma
NCT01123785	Completed	Trabodenoson monotherapy	A Dose-Escalation Study Designed to Evaluate the Tolerability, Safety, Pharmacokinetics (PK), and Efficacy of Chronic Topical Ocular Application of INO-8875 in Adults With Ocular Hypertension or Primary Open-Angle Glaucoma
NCT01123772	Completed	Trabodenoson monotherapy	Phase I Dose-Escalation Study to Evaluate Tolerability, Safety & PK of INO-8875 in Healthy Older-Adult Volunteers